Spectral Med Inc (EDT : TSX)
Common Stock
$1.33
CAD
-0.02 (-1.48%)
Last updated: 2026-07-13
EDT
Spectral Med Inc
WealthAwesomePerformance
1 Day
-1.48%
1 Week
-2.21%
1 Month
-3.62%
YTD
-3.62%
Key Statistics
Market Cap
$390.25M
52W High
$1.76
52W Low
$0.77
P/E Ratio
-
50 Day MA
$1.38
200 Day MA
$1.37
Beta
0.21
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/13/2026 | $1.38 | $1.38 | $1.33 | $1.33 | $1.33 | 32,395 |
| 7/10/2026 | $1.36 | $1.38 | $1.35 | $1.35 | $1.35 | 53,315 |
| 7/9/2026 | $1.36 | $1.36 | $1.33 | $1.34 | $1.34 | 21,100 |
| 7/8/2026 | $1.34 | $1.36 | $1.33 | $1.34 | $1.34 | 69,800 |
| 7/7/2026 | $1.33 | $1.36 | $1.31 | $1.33 | $1.33 | 83,887 |
| 7/6/2026 | $1.34 | $1.36 | $1.33 | $1.36 | $1.36 | 38,573 |
| 7/3/2026 | $1.31 | $1.35 | $1.31 | $1.33 | $1.33 | 20,829 |
| 7/2/2026 | $1.34 | $1.36 | $1.31 | $1.34 | $1.34 | 41,489 |
| 6/30/2026 | $1.33 | $1.33 | $1.29 | $1.32 | $1.32 | 39,372 |
| 6/29/2026 | $1.32 | $1.36 | $1.27 | $1.32 | $1.32 | 262,605 |
Analyst Price Targets
Based on analyst covering EDT
Wall Street analysts forecast EDT stock price to rise 136.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+136.8% Upside
Current Price
C$1.33
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
21.3%
Annualized
90-Day Vol
33.5%
Annualized
Trend (90d)
-15.5%
Annualized drift
90d Mean
C$1.26
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.31 | C$1.21 โ C$1.41 |
| 60 trading days | C$1.28 | C$1.16 โ C$1.42 |
| 90 trading days | C$1.26 | C$1.11 โ C$1.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $2.76M
- EBITDA
- $-10.66M
- Profit Margin
- 0.00%
- ROE (TTM)
- -973.97%
- EPS (Diluted)
- -0.13
- Book Value
- -0.24
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About EDT
Articles Featuring EDT.TO
Latest articles and analysis covering EDT.TO
What's Going On With Spectral Med Inc Stock Tuesday?
Spectral Med Inc (EDT.TO) has experienced a slight decline in stock price this week amid significant company developments, including an FDA filing for its PMX application. Investors should weigh the implications of these announcements against the stock's current performance metrics.
Why Spectral Med Inc stock is gaining today
Spectral Med Inc's stock has gained 1.49% in the last trading session, reflecting positive investor sentiment as the company progresses in its clinical trials and regulatory preparations.
Why Spectral Med Inc stock is sliding today
Spectral Med Inc (EDT.TO) is experiencing a challenging trading day, with a 2.94% drop in stock price. Investors are left wondering about the implications for the company's future, especially following its recent FDA application acceptance.
Why Spectral Med Inc stock is rising today
Spectral Med Inc's stock rose 2.21% in the last trading session, driven by positive trial results and strategic financial updates, making it a stock to watch for Canadian investors.
Why Spectral Med Inc stock is tanking today
Spectral Med Inc's stock price dropped by 1.45% in the last trading session, reflecting investor concerns amid a lack of recent positive news. With a market cap of approximately CA$404.9 million, investors are left wondering about the future trajectory of this biotech firm.
